CSRXP: LANDMARK OVERSIGHT REPORT DEBUNKS BIG PHARMA’S FALSE RHETORIC, ADDS TO MOMENTUM TO LOWER RX PRICES
Dec 10, 2021
U.S. House Oversight & Reform Committee Report Finds Big Pharma’s… Read More
© 2024 CSRXP- All Rights Reserved
Press Release
CSRxP: U.S. House Adds to Unprecedented Momentum to Hold Big Pharma Accountable with Passage of Rx Solutions in Build Back Better
Nov 19, 2021
Congress Must Capitalize on Historic Opportunity to Lower Drug Prices… Read More
CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS
Nov 12, 2021
Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical… Read More
CSRXP APPLAUDS INCLUSION OF PRESCRIPTION DRUG PRICING SOLUTIONS IN LATEST FRAMEWORK
Nov 2, 2021
Congress Should Reject Pharma-backed Proposals That Would Hike Health Care… Read More
CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES
Oct 28, 2021
Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the… Read More
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP
Oct 20, 2021
U.S. Food & Drug Administration Approval of Cyltezo Marks Second… Read More
CSRXP ENCOURAGES HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Sep 29, 2021
Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive… Read More
CSRXP POLL: MASSIVE MAJORITIES OF AMERICAN VOTERS SUPPORT SOLUTIONS TO LOWER DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE
Sep 14, 2021
Americans Blame Big Pharma for Out-of-Control Drug Prices, Reject Bogus… Read More
CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE
Sep 14, 2021
Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for… Read More
CSRXP APPLAUDS RELEASE OF HHS PLAN TO LOWER PRESCRIPTION DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE
Sep 9, 2021
Administration Proposal Would Increase Competition, Transparency and Value —… Read More
CSRXP APPLAUDS PRESIDENT BIDEN’S COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES AND CALL FOR CONGRESS TO ACT
Aug 12, 2021
Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver… Read More
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOLOGIC FOR INSULIN
Jul 29, 2021
Interchangeable Products Will Help Increase Prescription Drug Competition and… Read More